Navigation Links
Suture Express Files Antitrust Lawsuit Against Cardinal Health and Owens & Minor
Date:12/6/2012

OVERLAND PARK, Kan., Dec. 6, 2012 /PRNewswire/ -- Suture Express, the leading specialty distributor of suture, endomechanical and related surgical products, has filed an antitrust lawsuit in the United States Federal District Court for the District of Kansas against Cardinal Health and Owens & Minor, both broad-based wholesale distributors of medical and surgical supplies. 

The suit claims Cardinal Health and Owens & Minor abused their market power and engaged in anticompetitive behavior to prevent their customers from taking advantage of specialty suppliers, like Suture Express, which better serve customer needs within their specialties.  The suit seeks changes in business practices by Cardinal Health and Owens & Minor to create a level playing field, as well as more than $200 million in damages to compensate the company for lost sales.

"Cardinal Health and Owens & Minor contracts threaten customers with prohibitive financial penalties and other disincentives if they don't agree to include suture and endomechanical products in their orders," said Brian Forsythe, CEO of Suture Express.  "Imposing these financial penalties would make it financially impossible for customers to buy suture and endomechanical products from another distributor, even if offered significantly better service and prices."

The lawsuit alleges that Cardinal Health and Owens & Minor resorted to anticompetitive practices to protect their dominant market shares despite their inability to deliver suture and endomechanical products as efficiently or cost-effectively as Suture Express.  Availability of the right sutures and endomechanical products is critical both to doctors and to patients undergoing almost any invasive medical procedure.  However, because the product range is so great and the products are so specialized, the broad-based distributors stock a much smaller percentage of the products than specialty distributors like
'/>"/>

SOURCE Suture Express
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
2. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) Estimated to Reach USD 7.5 Billion Globally in 2017: Transparency Market Research
3. India Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
4. United States Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
5. Middle East and Africa Surgical Equipment Market Outlook to 2018 -Electrosurgical Devices, Hand Instruments and Surgical Sutures
6. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) - Global forecast, Market Share, size, growth and industry analysis (2010-2017)
7. Express Scripts to Present at Bank of America Merrill Lynch Conference
8. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
9. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
10. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
11. Generex Augments Antigen Express Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 The board of directors ... ) has declared a dividend for the third quarter ... stock. The dividend is payable September ... of business on August 15, 2013. Lilly, ... of pharmaceutical products by applying the latest research from ...
(Date:6/18/2013)... Today, Wall Street Reports announced new research reports ... Management Associates Inc. (NYSE: HMA ), IDEXX Laboratories, ... ISIS ), and Trius Therapeutics Inc. (NASDAQ: TSRX). ... including full price targets, industry analysis and analyst ratings - ... Report On June 7, 2013, Gilead Sciences Inc. ...
(Date:6/18/2013)... And EMERYVILLE, Calif. , ... presented final results today from a Phase 2/3 ... capsules demonstrating a statistically significant improvement in levodopa-induced ... at week 8 versus placebo in the Unified ... extended-release formulation of amantadine intended for once-nightly administration ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6
... , April 29, 2010 Albireo today,announced ... recent study,assessing the safety, tolerability and efficacy of A3309 ... compound for,the treatment of irritable bowel syndrome with constipation ... during the 2010,Digestive Disease Week (DDW) annual meeting being ...
... SALT LAKE CITY , April 28 Sonic Innovations, ... Administration (VA), is conducting ongoing training events for government clinicians.  The company ... in San Diego, California and April 25 through ... for May 3 through 5 in Salt Lake City, ...
Cached Medicine Technology:Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 2Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 3Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 4Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 5Sonic Innovations Conducts National Training Events for Government Clinicians 2Sonic Innovations Conducts National Training Events for Government Clinicians 3
(Date:6/18/2013)... The world,s first computer guided fitness training system ... of the three winners of the LeWeb,13 London ... , The startup company, Genetrainer, building on ... PhD graduate, Ralph Pethica and Julian Gough, Professor ... Science, was selected from over 350 startups to ...
(Date:6/18/2013)... June 18, 2013 On June 12th, ... everything about medical marijuana in Canada . ... republish the new Canadian Marijuana for Medical Purposes Regulation ... department of Health Canada. , The Canabud.ca website is ... rapidly growing industry. “As medical marijuana becomes more ...
(Date:6/18/2013)... GA (PRWEB) June 18, 2013 Dr. ... of the Atlanta Vision Institute, is pleased to announce ... next generation of Intralase LASIK equipment, the iFS™ Advanced ... only LASIK practice in Atlanta to offer its patients ... Ashraf is giving his patients a complimentary upgrade to ...
(Date:6/18/2013)... 2013 The Skin and Vein Center ... public on July 9 from 2 p.m. to 5 p.m. ... with the doctor or a nurse, who will give the ... or nurse will inform the patient of the health of ... available for varicose and spider veins. , As part of ...
(Date:6/18/2013)... NY (PRWEB) June 18, 2013 Visitors to New ... a spa promotion from the famed JW Marriott Essex House ... New York City for business or pleasure, guests can take a ... rejuvenating day surrounded by serenity at The Spa at Essex House. ... at the Central Park hotel starting at $379 per night plus ...
Breaking Medicine News(10 mins):Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2Health News:Kansas City Dermatologists at The Skin and Vein Center Offer Complimentary Vein Screening on July 9 2Health News:New Spa Deal From JW Marriott Essex House New York Will Delight, Relax Visitors 2Health News:New Spa Deal From JW Marriott Essex House New York Will Delight, Relax Visitors 3
... Johns Hopkins University School of Medicine have identified a ... novel autoantibody specificity that makes them potential candidates for ... September issue of Arthritis & Rheumatism , a ... Myopathy is a term used to describe muscle disease. ...
... Aug. 19 (HealthDay News)-- There were no smiles on the faces ... waiting on line for help from the Oregon Employment Department were ... lecture from a middle-aged woman, who leaned in close and whispered ... a lot of unhappy, stressed people here." At rows of ...
... the mainstream media has led many researchers to study ... have indicated that there is a link between exposure ... of sexual activity among teens. However, a study led ... Published this month in the online version of ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Aug. ... eggs has sickened more than 250 people and led to ... news reports. The outbreak, which apparently began in May, ... and Prevention said. On Aug. 13, the CDC said: ...
... School of Medicine in Baltimore have developed a novel ... treatment for ventricular tachycardia, a potentially life-threatening heart rhythm ... The new approach couples CT (computed tomography) images with ... the heart that produce arrhythmias. The results of a ...
... Center in Israel have determined that the use ... outcome for patients undergoing percutaneous coronary intervention (PCI), ... appear in the September issue of Catheterization ... Wiley-Blackwell on behalf of The Society for Cardiovascular ...
Cached Medicine News:Health News:Novel autoantibodies identified in patients with necrotizing myopathy 2Health News:Novel autoantibodies identified in patients with necrotizing myopathy 3Health News:Jobless and Stressed but Holding Out Hope 2Health News:For teens, early sex and media exposure not linked 2Health News:Nationwide Egg Recall Underway 2Health News:Innovative imaging system may boost speed and accuracy in treatment of heart rhythm disorder 2Health News:Innovative imaging system may boost speed and accuracy in treatment of heart rhythm disorder 3Health News:Innovative imaging system may boost speed and accuracy in treatment of heart rhythm disorder 4Health News:Drug-eluting stents confirmed safe, effective for long-term use 2
Ocuvite® vitamin and mineral supplements contain 2 mg of Lutein 8 times more than the leading multivitamins. Ocuvite also contains vitamin antioxidants A, C and E, as well as the minerals zinc, ...
... take their eyes for granted. Like ... eyes need proper nutrition and care ... vision as you age. In fact, ... to maintaining and preserving eye health ...
... The herbal extracts, vitamins, minerals, ... increases circulation to ocular tissue, ... healthy function of the lens ... This formula is optimized to ...
Online Unity Interlaboratory QC Data Management...
Medicine Products: